China approves new drug to treat Alzheimer’s; clinical trials planned for 2020 in US – WRAL Tech Wire

Authorities in China have approved a drug for the treatment of Alzheimer’s disease, the first new medicine with the potential to treat the cognitive disorder in 17 years.
The seaweed-based drug, called Oligomannate, can be used for the treatment of mild to m…

Click here to view the original article.